Skip to main content
. 2023 May 16;14(19):1812–1823. doi: 10.1111/1759-7714.14926

FIGURE 6.

FIGURE 6

PSAT1 was a target of miR‐5195‐3p. (a) Predicted miR‐5195‐3p binding sites in the 3'UTR of PSAT1. (b and c) Dual‐luciferase reporter assay was conducted to verify the predicted binding sites between PSAT1 and miR‐5195‐3p. (d) Analysis of PSAT1 mRNA levels in NSCLC samples and normal samples. (e) The correlation between miR‐5195‐3p and PSAT1 mRNA expression levels in NSCLC samples. (f–k) Analysis of PSAT1 mRNA and protein levels in non‐small cell lung cancer (NSCLC) cells (f and g), NSCLC cells with miR‐5195‐3p mimic or miR‐NC (h and i), and NSCLC cells with sh‐NC, sh‐circERBB2IP, sh‐circERBB2IP + in‐miR‐NC, or sh‐circERBB2IP + in‐miR‐5195‐3p (j and k). **p < 0.01 and ***p < 0.001.